Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.

Clinical trial NCT01262469 · COMPLETED

Trial details

NCT number: NCT01262469
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer 70 Years Old Patients and Over After One Line of Chemotherapy With Trastuzumab

Start date: 2009-12-01
Primary completion: 2011-12-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.